Experimental Study of the Effect of Cisapride on the Secretory of HCO3 in Rat's Gastricand its Relation with Nitric Oxide

Jing-song LIU,Xiao-hua Hou
DOI: https://doi.org/10.3870/j.issn.1005-541X.2001.01.011
2001-01-01
Abstract:This study was performed to study the mechanism of cisapride on gastric mucosa protection. Method: Rats were divided into control group (distilled water was infused orally), low dosage group (cisapride 0.5 mg/kg was infused orally), medium dosage group (cisapride 1 mg/kg was infused orally) and high dosage group (cisapride 2 mg/kg was infused orally). After infued alcohol 1.5 ml orally, the area of gastric ulcer, volume of nitric oxide in gastric mucosa and the output of HCO3- in gastric mucosa was measured. Result: The area of ulcer in 1 mog/kg group is significently lower than control group (10.2 ± 6.9 mm2 vs 26.1 ± 13.5 mm2, P < 0.05). The depth of ulcer in three cisapride groups are all significently lower than control group. The volume of nitric oxide in 1 mg/kg group is significently higher than control group (23.32±7.4 μmol/mg vs 16.93±3.87 μmol/mg, P<0.05). While in 2 rng/kg group, it's significently lower than control group(4.35 ± 1.52 μmol/mg). The output of HCO3- in 1 mg/kg group is higher than control group. Conclusion: Cisapride has protective effection on gastric mucosa. Cisapride 1 mg/kg can increase the volume of nitric oxide and the output of HCO3- . While cisapride 2 mg/kg can decrease the volume of nitric oxide and its protective effect is thinner than 1 mg/kg.
What problem does this paper attempt to address?